The KCE is an active member of several international networks such as:

  • EUnetHTA (European network for Health Technology Assessment), the European network for Health Technology Assessment with more than 30 states participating. The overall objective of EUnetHTA is to create an effective and sustainable network for HTA across Europe and to help develop reliable, timely, transparent and transferable information to support HTA in European countries. To do this, EUnetHTA produces a repository of methods and processes, and organises the collaborative production of Joint and Collaborative Assessments that can be used by member states.
  • INAHTA (International Network for Health Techology Assessment), the International Network of Agencies for Health Technology Assessment. It offers its members a forum to identify common interests in the evaluation of health technologies. INAHTA publishes the international HTA database of projects and reports and collaborates on the HTA Glossary project.
  • Beneluxa Initiative on Pharmaceutical Policy, an association of HTA agencies in the Benelux, Austria and, since 2018, Ireland. Its aim is to facilitate access to quality treatment at reasonable prices for patients in these countries. To this end, its members share Horizon Scanning exercises (anticipating health challenges by studying new pharmaceutical products entering the market), exchange information, expertise and best practices, and jointly negotiate the prices of new products entering their respective markets (resulting in greater price transparency).
  • IHSI (International Horizon Scanning Initiative), an international organisation that provides policy makers and payers with data to leverage in price negotiations with the pharmaceutical industry. This data allows health systems to prepare for the arrival of innovative technologies through early technology assessment of new products entering the market.
  • GIN (Guidelines International Network), an international organisation of organisations and experts involved in the development of clinical practice guidelines. The aim of the GIN is to contribute to the improvement of the quality of care by promoting the systematic development of guidelines and their implementation on an international scale.
  • ECRIN, an international non-profit organisation that networks European scientists involved in clinical research. Its objective is to facilitate transnational multicentre research by providing investigators with support and tools to manage the difficulties associated with the multinational nature of research. Belgium is not (yet) a member of ECRIN but the KCE Trials programme has regular contacts with this structure and its members in the context of international collaborations.
  • HTAi is the global scientific and professional organisation for health technology assessment. It is a neutral forum that brings together researchers, research agencies, policy makers, industry representatives, academics, healthcare providers, patient and consumer representatives and other stakeholders from 65 countries and 5 continents. HTAi organises an annual international scientific conference and collaborates on the HTA Glossary project. KCE staff members participate in working groups (e.g. the Patient and Citizen Involvement Group) and training courses.

KCE has excellent relationships with other scientific institutions conducting similar research in other countries such as NICE (United Kingdom), Zorginstituut Nederland (the Netherlands), HAS and INCa (France), IQWIG (Germany) or the Norwegian Institute of Public Health (Norway).